These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36645168)
1. A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects. Nakamura ZM; Deal AM; Park EM; Stanton KE; Lopez YE; Quillen LJ; O'Hare Kelly E; Heiling HM; Nyrop KA; Ray EM; Dees EC; Reeder-Hayes KE; Jolly TA; Carey LA; Abdou Y; Olajide OA; Rauch JK; Joseph R; Copeland A; McNamara MA; Ahles TA; Muss HB Cancer Med; 2023 Apr; 12(7):8172-8183. PubMed ID: 36645168 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292 [TBL] [Abstract][Full Text] [Related]
4. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Brown PD; Pugh S; Laack NN; Wefel JS; Khuntia D; Meyers C; Choucair A; Fox S; Suh JH; Roberge D; Kavadi V; Bentzen SM; Mehta MP; Watkins-Bruner D; Neuro Oncol; 2013 Oct; 15(10):1429-37. PubMed ID: 23956241 [TBL] [Abstract][Full Text] [Related]
5. Impact of integrated yoga therapy on cognitive impairment and cardiac dysfunction in relation to quality of life in breast cancer patients undergoing chemotherapy: Study protocol for a two-arm randomized controlled trial. Inbaraj G; Sathyaprabha TN; Udupa K; Ram A; Patil S; Rajeswaran J; Nandakumar KK; Belur S; Singh AD; Prathyusha PV; Bayari SK; Raghavendra RM Front Oncol; 2022; 12():955184. PubMed ID: 36185291 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study. Basen-Engquist KM; Raber M; Carmack CL; Arun B; Brewster AM; Fingeret M; Schembre SM; Harrison C; Perkins HY; Li Y; Song J; Chen M; Murray JL Support Care Cancer; 2020 Dec; 28(12):5821-5832. PubMed ID: 32249355 [TBL] [Abstract][Full Text] [Related]
11. Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial. Milbury K; Chaoul A; Biegler K; Wangyal T; Spelman A; Meyers CA; Arun B; Palmer JL; Taylor J; Cohen L Psychooncology; 2013 Oct; 22(10):2354-63. PubMed ID: 23657969 [TBL] [Abstract][Full Text] [Related]
12. Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis. Kennedy RE; Cutter GR; Fowler ME; Schneider LS JAMA Netw Open; 2018 Nov; 1(7):e184080. PubMed ID: 30646339 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series. Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567 [TBL] [Abstract][Full Text] [Related]
14. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia. Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903 [TBL] [Abstract][Full Text] [Related]
15. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Barton DL; Burger K; Novotny PJ; Fitch TR; Kohli S; Soori G; Wilwerding MB; Sloan JA; Kottschade LA; Rowland KM; Dakhil SR; Nikcevich DA; Loprinzi CL Support Care Cancer; 2013 Apr; 21(4):1185-92. PubMed ID: 23150188 [TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial. Costa ACS; Brandão AC; Boada R; Barrionuevo VL; Taylor HG; Roth E; Stasko MR; Johnson MW; Assir FF; Roberto MP; Salmona P; Abreu-Silveira G; Bederman I; Prendergast E; Hüls A; Abrishamcar S; Mustacchi Z; Scheidemantel T; Roizen NJ; Ruedrich S Lancet Neurol; 2022 Jan; 21(1):31-41. PubMed ID: 34942135 [TBL] [Abstract][Full Text] [Related]
17. Digital cognitive stimulation in elderly breast cancer patients: the Cog-Tab-Age feasibility study. Binarelli G; Lange M; Santos MD; Duivon M; Capel A; Fernette M; Boué A; Grellard JM; Tron L; Ahmed-Lecheheb D; Clarisse B; Rigal O; Le Fel J; Joly F BMC Complement Med Ther; 2024 May; 24(1):209. PubMed ID: 38822324 [TBL] [Abstract][Full Text] [Related]
18. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT. Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470 [TBL] [Abstract][Full Text] [Related]